GLAXOSMITHKLINE
Drug Manufacturers—General·London, DE, United Kingdom·$38.0B·NYSE: GSK
GSK is a global biopharmaceutical company focused on the research, development, and manufacturing of vaccines, medicines, and consumer healthcare products.
HEADQUARTERSLondon
CEOEmma Walmsley
SECTORHealthcare
EMPLOYEES70,000
IPO DATE2000
Active in:IC 001